Trial Profile
A Prospective, Observational study to assess the liver function using Magnetic Resonance Imaging (MRI) with Gadoxetic acid in patients with Liver injury and Cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2018
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver cirrhosis; Liver injury
- Focus Diagnostic use
- 16 May 2018 New trial record
- 14 Apr 2018 Results presented at The International Liver Congress 2018